MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with E

Estradiol + Dydrogesterone

Estradiol 1mg / Dydrogesterone 5mg tablets

No stability information

Stability notes for Estradiol 1mg / Dydrogesterone 5mg tablets

There are no stability notes for this medicine.

Suppliers (4) of Estradiol 1mg / Dydrogesterone 5mg tablets
Femoston-conti 1mg/5mg tablets (CST Pharma Ltd)
Femoston-conti 1mg/5mg tablets (Exeltis UK Ltd)
Femoston-conti 1mg/5mg tablets (Lexon (UK) Ltd)
Femoston-conti 1mg/5mg tablets (Necessity Supplies Ltd)

Estradiol 1mg / Dydrogesterone 10mg tablets

No stability information

Stability notes for Estradiol 1mg / Dydrogesterone 10mg tablets

There are no stability notes for this medicine.

Supplier

Estradiol 1mg / Dydrogesterone 10mg tablets (Exeltis UK Ltd)

Estradiol 2mg / Dydrogesterone 10mg tablets

No stability information

Stability notes for Estradiol 2mg / Dydrogesterone 10mg tablets

There are no stability notes for this medicine.

Suppliers

Estradiol 2mg / Dydrogesterone 10mg tablets (Exeltis UK Ltd)
Estradiol 2mg / Dydrogesterone 10mg tablets (Sigma Pharmaceuticals Plc)

Estradiol 500micrograms / Dydrogesterone 2.5mg tablets

No stability information

Stability notes for Estradiol 500micrograms / Dydrogesterone 2.5mg tablets

There are no stability notes for this medicine.

Suppliers

Femoston-conti 0.5mg/2.5mg tablets (CST Pharma Ltd)
Femoston-conti 0.5mg/2.5mg tablets (Exeltis UK Ltd)
Femoston-conti 0.5mg/2.5mg tablets (Necessity Supplies Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.